The first human trial of the treatment, which involves injecting treated white blood cells directly into the patient's spinal cord, helped three of five subjects regain muscle movement, according to company officials. Proneuron plans to begin human trials this year of another therapy for brain injuries, using antigens to spur the immune system to send healing T cells to the brain.

Related Summaries